The Board of Directors in their meeting held on today 14.08.2025, inter-alia considered and approved: (1) Un-audited standalone and consolidated financial results of the Company for the ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijay Solvex's board approved unaudited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025). Standalone revenue from operations rose about 21.7% YoY to Rs. 46,041.58 lacs from Rs. 37,829.35 lacs, while standalone net profit grew modestly to Rs. 101.75 lacs from Rs. 96.23 lacs. Consolidated net profit, however, fell sharply to Rs. 105.55 lacs from Rs. 192.76 lacs in Q1 FY25 due to lower share of profit from associates. The board fixed the 37th AGM for September 22, 2025, with book closure from September 16–22, 2025. Re-appointments of Shri Vijay Data as Managing Director and Shri Daya Kishan Data as Whole-time Director were approved, subject to shareholder approval. The auditor (Aggarwal Datta & Co.) issued an unmodified limited review report on both standalone and consolidated results.
Strong top-line growth signals healthy demand in the edible oils segment, but thin profit margins and a sharp dip in consolidated earnings (driven by associate companies) may temper investor enthusiasm. The director re-appointments and routine AGM items are procedural and unlikely to move the stock on their own.